For type 2 diabetes, GLP-1 receptor agonists are typically long-term therapies, similar to blood pressure or cholesterol medications
Common Side Effects Nausea Nausea is the most commonly reported side effect, particularly during the initial loading phase
Furthermore, a registered API supplier on the FDAs Green List recently received an FDA warning letter for repackaging and selling substances from other sources as their own, showing that even diligent compounding pharmacies may struggle to acquire safe ingredients
Resume dosing at the standard protocol dose
Retatrutide is a triple agonist activating GLP-1, GIP, and glucagon receptors
But she doesnt discourage nondiabetic patients who struggle with weight loss from looking into it: [For some people], a 5% to 10% weight loss has pretty significant benefits in terms of disease prevention and disease management, she says